Pharmaceutical companies will likely pursue tie-ups with biotech firms post-coronavirus due to their ability to develop novel treatments
Amazon Web Services' cloud capabilities — was previously able to develop a cancer vaccine in just 40 days. And the biotech's rapid development of a cancer vaccine underscores the promise of Moderna's approach to potentially develop a viable coronavirus vaccine — a development government officials have a deal to codevelop a vaccine.
The promise of the recent efforts of Moderna, BioNTech, and CureVac lie in their ability to rapidly develop a vaccine for novel diseases. And with the coronavirus growing into a pandemic, it's vital that a vaccine is developed and rolled out to the masses as expediently as possible. As pharmaceutical companies like Pfizer team up with biotech firms to combat the coronavirus, we think these legacy drugmakers will see biotechs' potential to speed up drug discovery first-hand and increasingly pursue partnerships with these firms once the coronavirus subsides to accelerate their own drug development and limit costs in the process.
Business Insider Intelligence analyzes the healthcare industry and provides in-depth analyst reports, proprietary forecasts, customizable charts, and more. >>, Business Insider Intelligence's expert email newsletter tailored for today's decision-makers in the healthcare industry, delivered to your inbox 6x a week. >>
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Hopes of a coronavirus vaccine mount as three key biotech players make progressDozens of companies and public labs around the world are working to develop a vaccine to prevent the spread of the flu-like virus.
続きを読む »
German vaccine company CureVac says no offers from Trump to buy exclusive vaccine accessA German biotech company says it did not receive an offer from President Trump to buy exclusive access to a coronavirus vaccine.
続きを読む »
AP Exclusive: Coronavirus vaccine test opens with 1st dosesU.S. researchers gave the first shots in first test of experimental coronavirus vaccine Monday, leading off worldwide hunt for protection as pandemic surges.
続きを読む »
Coronavirus vaccine trial starts Monday, government official saysA clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday.
続きを読む »
CureVac CEO interview, coronavirus vaccine development, controversy - Business InsiderEverything you need to know about CureVac, the German drugmaker working on a coronavirus vaccine that's at the heart of a US-German controversy
続きを読む »
Inside One Scientist's Fight to Contain Coronavirus Using DNADr. Kate Broderick, a molecular geneticist, is developing a vaccine to control coronavirus circulating in humans.
続きを読む »